PTS Antikörper (AA 1-111)

Produktnummer ABIN1885577

Der Kaninchen Polyklonal Anti-PTS-Antikörper wurde für WB, IF und IHC validiert. Er ist geeignet, PTS in Proben von Human zu detektieren.

Kurzübersicht für PTS Antikörper (AA 1-111) (ABIN1885577)

Target: PTS (6-Pyruvoyltetrahydropterin Synthase (PTS))

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser PTS Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), Immunofluorescence (IF), Immunohistochemistry (IHC)

Produktdetails anti-PTS Antikörper

Bindungsspezifität: AA 1-111

Aufreinigung: Purified by antigen-affinity chromatography.

Immunogen: Recombinant protein fragment contain a sequence corresponding to a region within amino acids 1 and 111 of human PTS

Anwendungsinformationen

Applikationshinweise: Suggested dilutions:
Western blotting: 1.500-1.3000
Immunohistochemistry: 1.50-1.500
Immunofluorescence: 1.100-1.200

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: 0.1 M Tris-buffered saline with 10 % Glycerol (pH 7.0).0.01 % Thimerosal was added as a preservative.

Konservierungsmittel: Thimerosal (Merthiolate)

Vorsichtsmaßnahmen: Biohazard Informations: This product contains thimerosal which is hazardous.

Lagerung: 4 °C/-20 °C

Informationen zur Lagerung: Store at -20 °C for long term preservation (recommended). Store at 4 °C for short term use.

Details zu PTS

Target: PTS (6-Pyruvoyltetrahydropterin Synthase (PTS))

Andere Bezeichnung: PTS

Hintergrund: The enzyme encoded by this gene catalyzes the elimination of inorganic triphosphate from dihydroneopterin triphosphate, which is the second and irreversible step in the biosynthesis of tetrahydrobiopterin from GTP.Tetrahydrobiopterin, also known as BH(4), is an essential cofactor and regulator of various enzyme activities, including enzymes involved in serotonin biosynthesis and NO synthase activity.Mutations in this gene result in hyperphenylalaninemia.[provided by RefSeq]

Molekulargewicht: 16 kDa

Gen-ID: 5805

NCBI Accession: NP_000308, NM_000317